• Citer

Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma.

par Marechal, Raphaël ;Mackey, John R;Lai, Raymond;Demetter, Pieter ;Peeters, Michel ;Polus, Marc;Cass, Carol E;Young, James;Salmon, Isabelle ;Devière, Jacques ;Van Laethem, Jean-Luc
Référence Clinical cancer research, 15, 8, page (2913-2919)
Publication Publié, 2009-04

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma.
Auteur:	Marechal, Raphaël; Mackey, John R; Lai, Raymond; Demetter, Pieter; Peeters, Michel; Polus, Marc; Cass, Carol E; Young, James; Salmon, Isabelle; Devière, Jacques; Van Laethem, Jean-Luc
Informations sur la publication:	Clinical cancer research, 15, 8, page (2913-2919)
Statut de publication:	Publié, 2009-04
Sujet CREF:	Sciences bio-médicales et agricoles
MeSH keywords:	Adenocarcinoma -- drug therapy
	Adenocarcinoma -- mortality
	Adenocarcinoma -- radiotherapy
	Adult
	Aged
	Aged, 80 and over
	Chemotherapy, Adjuvant
	Clinical Trials, Phase I as Topic
	Deoxycytidine -- administration & dosage
	Deoxycytidine -- analogs & derivatives
	Deoxycytidine -- therapeutic use
	Equilibrative Nucleoside Transporter 1 -- metabolism
	Female
	Follow-Up Studies
	Humans
	Male
	Membrane Transport Proteins -- metabolism
	Middle Aged
	Multivariate Analysis
	Neoplasm Recurrence, Local
	Pancreatic Neoplasms -- drug therapy
	Pancreatic Neoplasms -- mortality
	Pancreatic Neoplasms -- radiotherapy
Note générale:	Journal Article
	Research Support, Non-U.S. Gov't
	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:1078-0432
	info:doi/10.1158/1078-0432.CCR-08-2080
	info:pii/1078-0432.CCR-08-2080
	info:scp/65349163336
	info:pmid/19318496